688166BrightGene Bio-Medical Technology688166 info
$3.38info4.04%24h
Global rank6366
Market cap$1.43B
Change 7d-5.45%
YTD Performance-29.70%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    BrightGene Bio-Medical Technology (688166) Stock Overview

    BrightGene Bio-Medical Technology Co., Ltd., a pharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products in China. The company offers Eribulin mesylate injection, Voriconazole for injection, Entecavir tablets, Oseltamivir phosphate capsule and dry suspension, Agatroban injection, Mikafungin sodium for injection, Fondaparinux sodium injection, and Caspofungin acetate for injection. It also provides antitumor, antibodies drug conjugate, anti-infection, angiography, gynecology, cardiovascular, cerebrovascular, iron supplement, digestion, and other APIs and intermediates. In addition, the company offers veterinary drugs. BrightGene Bio-Medical Technology Co., Ltd. was founded in 2001 and is based in Suzhou, China.

    688166 Stock Information

    Symbol
    688166
    Address
    Building C25-28Suzhou, 215123China
    Founded
    -
    Trading hours
    9:30 AM - 3:00 PM CST
    Website
    https://www.bright-gene.com
    Country
    🇨🇳 China
    Phone Number
    86 512 6262 0988

    BrightGene Bio-Medical Technology (688166) Price Chart

    -
    Value:-

    BrightGene Bio-Medical Technology Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $3.38
    N/A
    Market Cap
    $1.43B
    N/A
    Shares Outstanding
    422.47M
    N/A
    Employees
    1.13K
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org